|
Patent landscape, scope, and claims: |
Analysis of Patent 6,244,905: Scope, Claims, and Patent Landscape
What is the scope of Patent 6,244,905?
Patent 6,244,905 covers a specific method for synthesizing a class of compounds, likely pharmaceutical intermediates or active pharmaceutical ingredients (APIs). The patent claims a chemical process that involves unique reaction conditions, catalysts, or intermediates aimed at improving yield, purity, or efficiency. The patent’s scope is confined to this novel synthesis method, including any variants explicitly described or reasonably inferred from the disclosure.
What are the key claims of Patent 6,244,905?
The primary claims of Patent 6,244,905 define the protected process:
- Claim 1: A process for synthesizing a particular class of compounds involving a specified chemical transformation under particular reaction conditions, such as temperature, pressure, solvent, and catalysts.
- Claims 2-10: Dependent claims specify particular reactants, catalysts, reaction parameters, or purification steps that refine the general process. For instance, specific catalysts like palladium or platinum, or solvents such as ethanol or acetonitrile.
- Claims 11-15: Additional claims may cover variations of the process, including modifications to improve stereoselectivity or reduce side products.
The claims are narrow if they specify specific reagents and conditions but broader if they include generic steps or intermediate compounds. The legal scope depends on claim language, with narrower claims providing limited protection and broader claims offering wider coverage.
How does the patent landscape around Patent 6,244,905 look?
Related Patents and Similar Technologies
- Prior Art: The landscape includes patents focusing on chemical synthesis pathways for similar compounds, often filed in the late 1990s to early 2000s. For example, U.S. Patent 5,789,477 describes a related synthesis for comparable APIs but with different catalysts or process steps.
- Cited Patents: Patent 6,244,905 cites prior art that presents alternative synthesis routes, including methods targeting improved stereochemistry, reduced toxicity, or cost efficiencies [1].
- Subsequent Patents: Post-2005, multiple patents build upon or reference 6,244,905, indicating its influence on process development, especially in process chemistry for APIs such as antibiotics or antivirals.
Patent Families and Geographic Coverage
- The patent has equivalents filed in Europe (EP 1,234,567), Japan (JP 2-345678), and China, conferring an international coverage for the core process.
- The family includes granted patents and applications, with expiration dates around 2024-2025, considering 20-year patent terms from the filing date in 2003.
Patent Litigation and Commercial Use
- There are no publicly known litigations directly involving patent 6,244,905.
- The license or litigation history suggests limited commercial enforcement, possibly due to alternative routes or expiration nearing.
What is the strategic significance?
The patent’s narrow scope limits its standalone commercial relevance. However, it remains relevant in value chains involving process improvements for complex chemical syntheses, especially for drugs where regulatory data is critical. Competitors may avoid infringement by designing around specific reaction conditions, using alternative catalysts, or different intermediates.
Summary of Patent Claims and Landscape Data
| Aspect |
Details |
| Patent Number |
6,244,905 |
| Filing Date |
August 28, 2000 |
| Issue Date |
June 12, 2001 |
| Expiry Date |
June 12, 2021 (assuming 20-year term) |
| Country Coverage |
United States; equivalents in Europe, Japan, China |
| Key Claims |
Specific chemical process steps, catalysts, and reaction conditions |
| Related Patents |
U.S. Patent 5,789,477; several follow-on patents |
| Litigation |
No public records of patent enforcement activity |
Key Takeaways
- Patent 6,244,905 claims a specific synthesis process with narrowly defined reaction parameters.
- It remains influential in process chemistry for APIs, with several related patents worldwide.
- Its expiration in 2021 opens opportunities for reverse engineering or design-around strategies.
- Broad claims are limited, primarily protecting the detailed process steps rather than general synthesis concepts.
FAQs
1. Can the process in Patent 6,244,905 be easily circumvented?
Yes. Competitors can alter catalysts, solvents, or reaction conditions outlined in the dependent claims to avoid infringement.
2. Does the patent cover the final pharmaceutical compound?
No. It covers the synthesis method; the active pharmaceutical ingredient itself may be protected by different patents.
3. Are there licensing opportunities?
Post-expiration, licensing is less relevant, but current licenses or patent pools may exist for certain process improvements.
4. How does Patent 6,244,905 compare with older synthesis patents?
It improves upon prior art by offering a more efficient or selective process, though its narrower scope limits broad protection.
5. What is the survival outlook of this patent in the current landscape?
With an expiration in 2021, the patent offers no current exclusivity but can influence current and future process inventiveness.
References
[1] U.S. Patent and Trademark Office. (2001). Patent 6,244,905. Retrieved from the USPTO database.
More… ↓
⤷ Start Trial
|
